{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T01:17:34Z","timestamp":1794359854544,"version":"4.9.0"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T00:00:00Z","timestamp":1764201600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T00:00:00Z","timestamp":1764201600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Graduate Research Fund of Zunyi Medical University","award":["ZYK159"],"award-info":[{"award-number":["ZYK159"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-26378-2","type":"journal-article","created":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T12:55:05Z","timestamp":1764248105000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Development and validation of nomogram and machine learning models to predict sarcopenia in patients with chronic kidney disease"],"prefix":"10.1038","volume":"15","author":[{"given":"Yan","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zongyue","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huaize","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuqiu","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chu","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuemei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,27]]},"reference":[{"key":"26378_CR1","doi-asserted-by":"publisher","unstructured":"Global & national burden of chronic kidney disease. and, 1990\u20132017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet.\u00a033 395\u2013709 (2020). https:\/\/doi.org\/10.1016\/S0140-6736(20)30045-3","DOI":"10.1016\/S0140-6736(20)30045-3"},{"key":"26378_CR2","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1093\/ckj\/sfac218","volume":"16","author":"Y Li","year":"2023","unstructured":"Li, Y. et al. Temporal trends in prevalence and mortality for chronic kidney disease in China from 1990 to 2019: an analysis of the global burden of disease study 2019. Clin. Kidney J. 16, 312\u2013321. https:\/\/doi.org\/10.1093\/ckj\/sfac218 (2023).","journal-title":"Clin. Kidney J."},{"key":"26378_CR3","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.1093\/cvr\/cvad083","volume":"119","author":"C Zoccali","year":"2023","unstructured":"Zoccali, C. et al. Cardiovascular complications in chronic kidney disease: a review from the European renal and cardiovascular medicine working group of the European renal association. Cardiovasc. Res. 119, 2017\u20132032. https:\/\/doi.org\/10.1093\/cvr\/cvad083 (2023).","journal-title":"Cardiovasc. Res."},{"key":"26378_CR4","doi-asserted-by":"publisher","unstructured":"Wang, B. et al. Hypoxia and chronic kidney disease. EBioMedicine. 77:103942. (2022). https:\/\/doi.org\/10.1016\/j.ebiom.2022.103942","DOI":"10.1016\/j.ebiom.2022.103942"},{"key":"26378_CR5","doi-asserted-by":"publisher","unstructured":"Sim\u00f5es, E., Silva, A. C., Oliveira, E. A., Cheung, W. W. & Mak, R. H. Redox signaling in chronic kidney Disease-Associated cachexia. Antioxid. (Basel). 12. https:\/\/doi.org\/10.3390\/antiox12040945 (2023).","DOI":"10.3390\/antiox12040945"},{"key":"26378_CR6","doi-asserted-by":"publisher","unstructured":"Mori, K. Maintenance of skeletal muscle to counteract sarcopenia in patients with advanced chronic kidney disease and especially those undergoing Hemodialysis. Nutrients 13 https:\/\/doi.org\/10.3390\/nu13051538 (2021).","DOI":"10.3390\/nu13051538"},{"key":"26378_CR7","doi-asserted-by":"publisher","unstructured":"Sayer, A. A. & Cruz-Jentoft, A. Sarcopenia definition, diagnosis and treatment: consensus is growing. Age Ageing. 51. https:\/\/doi.org\/10.1093\/ageing\/afac220 (2022).","DOI":"10.1093\/ageing\/afac220"},{"key":"26378_CR8","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1002\/jcsm.13425","volume":"15","author":"MP Duarte","year":"2024","unstructured":"Duarte, M. P. et al. Prevalence of sarcopenia in patients with chronic kidney disease: a global systematic review and meta-analysis. J. Cachexia Sarcopenia Muscle. 15, 501\u2013512. https:\/\/doi.org\/10.1002\/jcsm.13425 (2024).","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"26378_CR9","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1002\/jcsm.13260","volume":"14","author":"M Okamura","year":"2023","unstructured":"Okamura, M. et al. Kidney function in cachexia and sarcopenia: facts and numbers. J. Cachexia Sarcopenia Muscle. 14, 1589\u20131595. https:\/\/doi.org\/10.1002\/jcsm.13260 (2023).","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"26378_CR10","doi-asserted-by":"publisher","first-page":"153393","DOI":"10.1016\/j.phymed.2020.153393","volume":"80","author":"S Jiang","year":"2021","unstructured":"Jiang, S. et al. Dojuksan ameliorates tubulointerstitial fibrosis through irisin-mediated muscle-kidney crosstalk. Phytomedicine: Int. J. Phytotherapy Phytopharmacology. 80, 153393. https:\/\/doi.org\/10.1016\/j.phymed.2020.153393 (2021).","journal-title":"Phytomedicine: Int. J. Phytotherapy Phytopharmacology"},{"key":"26378_CR11","doi-asserted-by":"publisher","first-page":"115407","DOI":"10.1016\/j.bcp.2022.115407","volume":"208","author":"K Wang","year":"2023","unstructured":"Wang, K. et al. Chronic kidney disease-induced muscle atrophy: molecular mechanisms and promising therapies. Biochem. Pharmacol. 208, 115407. https:\/\/doi.org\/10.1016\/j.bcp.2022.115407 (2023).","journal-title":"Biochem. Pharmacol."},{"key":"26378_CR12","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1038\/nrneph.2011.60","volume":"7","author":"K Kalantar-Zadeh","year":"2011","unstructured":"Kalantar-Zadeh, K. et al. Diets and enteral supplements for improving outcomes in chronic kidney disease. Nat. Rev. Nephrol. 7, 369\u2013384. https:\/\/doi.org\/10.1038\/nrneph.2011.60 (2011).","journal-title":"Nat. Rev. Nephrol."},{"key":"26378_CR13","doi-asserted-by":"publisher","unstructured":"Heitman, K. et al. Hyperphosphatemia Contributes to Skeletal Muscle Atrophy in Mice. Int. J. Mol. Sci. 25. https:\/\/doi.org\/10.3390\/ijms25179308 (2024).","DOI":"10.3390\/ijms25179308"},{"key":"26378_CR14","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/j.kint.2018.10.010","volume":"95","author":"D Verzola","year":"2019","unstructured":"Verzola, D., Barisione, C., Picciotto, D., Garibotto, G. & Koppe, L. Emerging role of myostatin and its Inhibition in the setting of chronic kidney disease. Kidney Int. 95, 506\u2013517. https:\/\/doi.org\/10.1016\/j.kint.2018.10.010 (2019).","journal-title":"Kidney Int."},{"key":"26378_CR15","doi-asserted-by":"publisher","unstructured":"Inaba, M., Okuno, S. & Ohno, Y. Importance of considering malnutrition and sarcopenia in order to improve the QOL of elderly Hemodialysis patients in Japan in the era of 100-Year life. Nutrients 13 https:\/\/doi.org\/10.3390\/nu13072377 (2021).","DOI":"10.3390\/nu13072377"},{"key":"26378_CR16","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1093\/ndt\/gfad243","volume":"39","author":"G Wu","year":"2024","unstructured":"Wu, G. et al. Sarcopenia and mild kidney dysfunction and risk of all-cause and cause-specific mortality in older adults. Nephrol. Dialysis Transplantation: Official Publication Eur. Dialysis Transpl. Association - Eur. Ren. Association. 39, 989\u2013999. https:\/\/doi.org\/10.1093\/ndt\/gfad243 (2024).","journal-title":"Nephrol. Dialysis Transplantation: Official Publication Eur. Dialysis Transpl. Association - Eur. Ren. Association"},{"key":"26378_CR17","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1093\/eurjpc\/zwae130","volume":"31","author":"E Kouidi","year":"2024","unstructured":"Kouidi, E. et al. The role of exercise training on cardiovascular risk factors and heart disease in patients with chronic kidney disease G3-G5 and G5D: a clinical consensus statement of the European association of preventive cardiology of the ESC and the European association of rehabilitation in chronic kidney disease. Eur. J. Prev. Cardiol. 31, 1493\u20131515. https:\/\/doi.org\/10.1093\/eurjpc\/zwae130 (2024).","journal-title":"Eur. J. Prev. Cardiol."},{"key":"26378_CR18","doi-asserted-by":"publisher","first-page":"116975","DOI":"10.1016\/j.bone.2023.116975","volume":"179","author":"Y Nakano","year":"2024","unstructured":"Nakano, Y. et al. Effect of osteosarcopenia on longitudinal mortality risk and chronic kidney disease progression in older adults. Bone 179, 116975. https:\/\/doi.org\/10.1016\/j.bone.2023.116975 (2024).","journal-title":"Bone"},{"key":"26378_CR19","doi-asserted-by":"publisher","unstructured":"Lin, T-Y., Wu, M-Y., Chen, H-S., Hung, S-C. & Lim, P-S. Development and validation of a multifrequency bioimpedance spectroscopy equation to predict appendicular skeletal muscle mass in hemodialysis patients. Clinical Nutrition (Edinburgh, Scotland). 40:3288-95. (2021). https:\/\/doi.org\/10.1016\/j.clnu.2020.10.056","DOI":"10.1016\/j.clnu.2020.10.056"},{"key":"26378_CR20","doi-asserted-by":"publisher","unstructured":"Czaja-Stolc, S. et al. Adipokines and myokines as markers of malnutrition and sarcopenia in patients receiving kidney replacement therapy: an Observational, Cross-Sectional study. Nutrients 16 https:\/\/doi.org\/10.3390\/nu16152480 (2024).","DOI":"10.3390\/nu16152480"},{"key":"26378_CR21","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1093\/ije\/dys203","volume":"43","author":"Y Zhao","year":"2014","unstructured":"Zhao, Y., Hu, Y., Smith, J. P., Strauss, J. & Yang, G. Cohort profile: the China health and retirement longitudinal study (CHARLS). Int. J. Epidemiol. 43, 61\u201368. https:\/\/doi.org\/10.1093\/ije\/dys203 (2014).","journal-title":"Int. J. Epidemiol."},{"key":"26378_CR22","doi-asserted-by":"publisher","unstructured":"Chen, L-K. et al. Asian working group for sarcopenia: 2019 consensus update on sarcopenia diagnosis and treatment. J. Am. Med. Dir. Assoc. 21. https:\/\/doi.org\/10.1016\/j.jamda.2019.12.012 (2020).","DOI":"10.1016\/j.jamda.2019.12.012"},{"key":"26378_CR23","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1186\/s13098-024-01467-w","volume":"16","author":"M Zou","year":"2024","unstructured":"Zou, M. & Shao, Z. Construction and evaluation of sarcopenia risk prediction model for patients with diabetes: a study based on the China health and retirement longitudinal study (CHARLS). Diabetol. Metab. Syndr. 16, 230. https:\/\/doi.org\/10.1186\/s13098-024-01467-w (2024).","journal-title":"Diabetol. Metab. Syndr."},{"key":"26378_CR24","doi-asserted-by":"publisher","unstructured":"Gao, K. et al. Association between sarcopenia and cardiovascular disease among middle-aged and older adults: Findings from the China health and retirement longitudinal study. EClinicalMedicine. 44:101264. (2022). https:\/\/doi.org\/10.1016\/j.eclinm.2021.101264","DOI":"10.1016\/j.eclinm.2021.101264"},{"key":"26378_CR25","doi-asserted-by":"publisher","unstructured":"Chou, A. et al. Moderating Effects of Informal Care on the Relationship Between ADL Limitations and Adverse Outcomes in Stroke Survivors. Stroke. 55:1554-61. (2024). https:\/\/doi.org\/10.1161\/STROKEAHA.123.045427","DOI":"10.1161\/STROKEAHA.123.045427"},{"key":"26378_CR26","doi-asserted-by":"publisher","unstructured":"Oort, Q. et al. Instrumental activities of daily living in neuro-oncology: international validation of the EORTC IADL-BN32 questionnaire. Eur. J. Cancer (Oxford England: 1990). 212 (114335). https:\/\/doi.org\/10.1016\/j.ejca.2024.114335 (2024).","DOI":"10.1016\/j.ejca.2024.114335"},{"key":"26378_CR27","doi-asserted-by":"publisher","first-page":"e1005","DOI":"10.1016\/S2468-2667(22)00203-1","volume":"7","author":"J Gong","year":"2022","unstructured":"Gong, J. et al. Nowcasting and forecasting the care needs of the older population in china: analysis of data from the China health and retirement longitudinal study (CHARLS). Lancet Public. Health. 7, e1005\u2013e13. https:\/\/doi.org\/10.1016\/S2468-2667(22)00203-1 (2022).","journal-title":"Lancet Public. Health"},{"key":"26378_CR28","doi-asserted-by":"publisher","first-page":"154297","DOI":"10.1016\/j.scitotenv.2022.154297","volume":"828","author":"Y Yao","year":"2022","unstructured":"Yao, Y., Wang, K. & Xiang, H. Association between cognitive function and ambient particulate matters in middle-aged and elderly Chinese adults: evidence from the China health and retirement longitudinal study (CHARLS). Sci. Total Environ. 828, 154297. https:\/\/doi.org\/10.1016\/j.scitotenv.2022.154297 (2022).","journal-title":"Sci. Total Environ."},{"key":"26378_CR29","doi-asserted-by":"publisher","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","volume":"150","author":"AS Levey","year":"2009","unstructured":"Levey, A. S. et al. A new equation to estimate glomerular filtration rate. Ann. Intern. Med. 150, 604\u2013612 (2009).","journal-title":"Ann. Intern. Med."},{"key":"26378_CR30","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s12944-024-02048-6","volume":"23","author":"H Zhang","year":"2024","unstructured":"Zhang, H., Zhang, Y., Gao, W. & Mu, Y. Identification of risk factors and development of a predictive model for chronic kidney disease in patients with obesity: a four-year cohort study. Lipids Health Dis. 23, 57. https:\/\/doi.org\/10.1186\/s12944-024-02048-6 (2024).","journal-title":"Lipids Health Dis."},{"key":"26378_CR31","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/s41572-024-00550-w","volume":"10","author":"AA Sayer","year":"2024","unstructured":"Sayer, A. A. et al. Sarcopenia. Nat. Rev. Dis. Primers. 10, 68. https:\/\/doi.org\/10.1038\/s41572-024-00550-w (2024).","journal-title":"Nat. Rev. Dis. Primers"},{"key":"26378_CR32","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1002\/jcsm.12941","volume":"13","author":"Y Otsuka","year":"2022","unstructured":"Otsuka, Y. et al. Effects of resistance training intensity on muscle quantity\/quality in middle-aged and older people: a randomized controlled trial. J. Cachexia Sarcopenia Muscle. 13, 894\u2013908. https:\/\/doi.org\/10.1002\/jcsm.12941 (2022).","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"26378_CR33","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1186\/s12877-023-03823-3","volume":"23","author":"F Bu","year":"2023","unstructured":"Bu, F. et al. Development and validation of a risk prediction model for frailty in patients with diabetes. BMC Geriatr. 23, 172. https:\/\/doi.org\/10.1186\/s12877-023-03823-3 (2023).","journal-title":"BMC Geriatr."},{"key":"26378_CR34","doi-asserted-by":"publisher","unstructured":"Gao, Q. et al. Associated Factors of Sarcopenia in Community-Dwelling Older Adults: A Systematic Review and Meta-Analysis. Nutrients. 13. (2021). https:\/\/doi.org\/10.3390\/nu13124291","DOI":"10.3390\/nu13124291"},{"key":"26378_CR35","doi-asserted-by":"publisher","unstructured":"Yuan, S. & Larsson, S. C. Epidemiology of sarcopenia: Prevalence, risk factors, and consequences. Metabolism. 144:155533. (2023). https:\/\/doi.org\/10.1016\/j.metabol.2023.155533","DOI":"10.1016\/j.metabol.2023.155533"},{"key":"26378_CR36","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1002\/jcsm.13141","volume":"14","author":"M Guo","year":"2023","unstructured":"Guo, M. et al. Irisin ameliorates age-associated sarcopenia and metabolic dysfunction. J. Cachexia Sarcopenia Muscle. 14, 391\u2013405. https:\/\/doi.org\/10.1002\/jcsm.13141 (2023).","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"26378_CR37","doi-asserted-by":"publisher","first-page":"2589","DOI":"10.1002\/jcsm.13107","volume":"13","author":"A Boshnjaku","year":"2022","unstructured":"Boshnjaku, A. Is age-related sarcopenia a real concern for my developing country? J. Cachexia Sarcopenia Muscle. 13, 2589\u20132592. https:\/\/doi.org\/10.1002\/jcsm.13107 (2022).","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"26378_CR38","doi-asserted-by":"publisher","first-page":"101852","DOI":"10.1016\/j.arr.2023.101852","volume":"86","author":"G Livshits","year":"2023","unstructured":"Livshits, G. & Kalinkovich, A. A cross-talk between sestrins, chronic inflammation and cellular senescence governs the development of age-associated sarcopenia and obesity. Ageing Res. Rev. 86, 101852. https:\/\/doi.org\/10.1016\/j.arr.2023.101852 (2023).","journal-title":"Ageing Res. Rev."},{"key":"26378_CR39","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1016\/j.jhep.2019.02.004","volume":"70","author":"C Francoz","year":"2019","unstructured":"Francoz, C. & Sola, E. Assessment of renal function in cirrhosis: Sarcopenia, gender and ethnicity matter. J. Hepatol. 70, 828\u2013830. https:\/\/doi.org\/10.1016\/j.jhep.2019.02.004 (2019).","journal-title":"J. Hepatol."},{"key":"26378_CR40","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1002\/jcsm.12839","volume":"12","author":"O Gungor","year":"2021","unstructured":"Gungor, O., Ulu, S., Hasbal, N. B., Anker, S. D. & Kalantar-Zadeh, K. Effects of hormonal changes on sarcopenia in chronic kidney disease: where are we now and what can we do? J. Cachexia Sarcopenia Muscle. 12, 1380\u20131392. https:\/\/doi.org\/10.1002\/jcsm.12839 (2021).","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"26378_CR41","doi-asserted-by":"publisher","first-page":"e12989","DOI":"10.1111\/cpr.12989","volume":"54","author":"C-W Li","year":"2021","unstructured":"Li, C-W. et al. Sterol metabolism and protein metabolism are differentially correlated with sarcopenia in Asian Chinese men and women. Cell. Prolif. 54, e12989. https:\/\/doi.org\/10.1111\/cpr.12989 (2021).","journal-title":"Cell. Prolif."},{"key":"26378_CR42","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1002\/jcsm.13213","volume":"14","author":"M Deng","year":"2023","unstructured":"Deng, M. et al. Glycyl-l-histidyl-l-lysine-Cu2\u2009+\u2009rescues cigarette smoking-induced skeletal muscle dysfunction via a Sirtuin 1-dependent pathway. J. Cachexia Sarcopenia Muscle. 14, 1365\u20131380. https:\/\/doi.org\/10.1002\/jcsm.13213 (2023).","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"26378_CR43","doi-asserted-by":"publisher","unstructured":"Liu, M. et al. Causal roles of Lifestyle, psychosocial Characteristics, and sleep status in sarcopenia: A Mendelian randomization Study. The journals of gerontology series A, biological sciences and medical sciences. 79. (2024). https:\/\/doi.org\/10.1093\/gerona\/glad191","DOI":"10.1093\/gerona\/glad191"},{"key":"26378_CR44","doi-asserted-by":"publisher","unstructured":"Zheng, G. et al. HDAC9 Inhibition reduces skeletal muscle atrophy and enhances regeneration in mice with cigarette smoke-induced COPD. Biochim. Et Biophys. Acta Mol. Basis Disease. 1870 (167023). https:\/\/doi.org\/10.1016\/j.bbadis.2024.167023 (2024).","DOI":"10.1016\/j.bbadis.2024.167023"},{"key":"26378_CR45","doi-asserted-by":"publisher","unstructured":"Morwani-Mangnani, J. et al. Gut microbiome changes due to sleep disruption in older and younger individuals: a case for sarcopenia? Sleep. 45. (2022). https:\/\/doi.org\/10.1093\/sleep\/zsac239","DOI":"10.1093\/sleep\/zsac239"},{"key":"26378_CR46","doi-asserted-by":"publisher","first-page":"e2300599","DOI":"10.1002\/mnfr.202300599","volume":"68","author":"H Zhu","year":"2024","unstructured":"Zhu, H., Zhao, H., Qian, H., Liu, C. & Urolithin A ameliorates athletic ability and intestinal microbiota in sleep deprivation from the perspective of the Gut-Muscle axis. Mol. Nutr. Food Res. 68, e2300599. https:\/\/doi.org\/10.1002\/mnfr.202300599 (2024).","journal-title":"Mol. Nutr. Food Res."},{"key":"26378_CR47","doi-asserted-by":"publisher","unstructured":"Meza-Valderrama, D. et al. Sarcopenia, Malnutrition, and Cachexia: Adapting Definitions and Terminology of Nutritional Disorders in Older People with Cancer. Nutrients 13. https:\/\/doi.org\/10.3390\/nu13030761 (2021).","DOI":"10.3390\/nu13030761"},{"key":"26378_CR48","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s13045-023-01454-0","volume":"16","author":"T Setiawan","year":"2023","unstructured":"Setiawan, T. et al. Cancer cachexia: molecular mechanisms and treatment strategies. J. Hematol. Oncol. 16, 54. https:\/\/doi.org\/10.1186\/s13045-023-01454-0 (2023).","journal-title":"J. Hematol. Oncol."},{"key":"26378_CR49","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1001\/jamaoncol.2023.5232","volume":"10","author":"O Arrieta","year":"2024","unstructured":"Arrieta, O. et al. Mirtazapine as appetite stimulant in patients with Non-Small cell lung cancer and anorexia: A randomized clinical trial. JAMA Oncol. 10, 305\u2013314. https:\/\/doi.org\/10.1001\/jamaoncol.2023.5232 (2024).","journal-title":"JAMA Oncol."},{"key":"26378_CR50","doi-asserted-by":"publisher","first-page":"2196","DOI":"10.1002\/jcsm.13302","volume":"14","author":"KJ Kim","year":"2023","unstructured":"Kim, K. J., Son, S., Kim, K. J., Kim, S. G. & Kim, N. H. Weight-adjusted waist as an integrated index for fat, muscle and bone health in adults. J. Cachexia Sarcopenia Muscle. 14, 2196\u20132203. https:\/\/doi.org\/10.1002\/jcsm.13302 (2023).","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"26378_CR51","doi-asserted-by":"publisher","unstructured":"Lin, Y-L. et al. Serum creatinine to Cystatin C ratio predicts skeletal muscle mass and strength in patients with non-dialysis chronic kidney disease. Clin. Nutr. 39 (2435-41). https:\/\/doi.org\/10.1016\/j.clnu.2019.10.027 (2020).","DOI":"10.1016\/j.clnu.2019.10.027"},{"key":"26378_CR52","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1186\/s12877-022-03643-x","volume":"22","author":"MC Yoo","year":"2022","unstructured":"Yoo, M. C., Won, C. W. & Soh, Y. Association of high body mass index, waist circumference, and body fat percentage with sarcopenia in older women. BMC Geriatr. 22, 937. https:\/\/doi.org\/10.1186\/s12877-022-03643-x (2022).","journal-title":"BMC Geriatr."},{"key":"26378_CR53","doi-asserted-by":"publisher","unstructured":"Curtis, M., Swan, L., Fox, R., Warters, A. & O\u2019Sullivan, M. Associations between Body Mass Index and Probable Sarcopenia in Community-Dwelling Older Adults. Nutrients 15. https:\/\/doi.org\/10.3390\/nu15061505 (2023).","DOI":"10.3390\/nu15061505"},{"key":"26378_CR54","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1001\/jamacardio.2022.4277","volume":"8","author":"NH Adamstein","year":"2023","unstructured":"Adamstein, N. H. et al. Association of Interleukin 6 Inhibition with Ziltivekimab and the Neutrophil-Lymphocyte ratio: A secondary analysis of the RESCUE clinical trial. JAMA Cardiol. 8, 177\u2013181. https:\/\/doi.org\/10.1001\/jamacardio.2022.4277 (2023).","journal-title":"JAMA Cardiol."},{"key":"26378_CR55","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1186\/s12964-024-01922-1","volume":"22","author":"G Zheng","year":"2024","unstructured":"Zheng, G., Cao, J., Wang, X. H., He, W. & Wang, B. The gut microbiome, chronic kidney disease, and sarcopenia. Cell. Commun. Signal. 22, 558. https:\/\/doi.org\/10.1186\/s12964-024-01922-1 (2024).","journal-title":"Cell. Commun. Signal."},{"key":"26378_CR56","doi-asserted-by":"publisher","DOI":"10.1002\/jcsm.13637","author":"A Gokdeniz Yildirim","year":"2024","unstructured":"Gokdeniz Yildirim, A., Kaya, D., Dost, F. S., Ontan, M. S. & Isik, A. T. Sarcopenia seems to be common in older patients with restless legs syndrome. J. Cachexia Sarcopenia Muscle. https:\/\/doi.org\/10.1002\/jcsm.13637 (2024).","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"26378_CR57","doi-asserted-by":"publisher","first-page":"sfae010","DOI":"10.1093\/ckj\/sfae010","volume":"17","author":"T Phillips","year":"2024","unstructured":"Phillips, T. et al. Potentially modifiable factors associated with health-related quality of life among people with chronic kidney disease: baseline findings from the National unified renal translational research enterprise CKD (NURTuRE-CKD) cohort. Clin. Kidney J. 17, sfae010. https:\/\/doi.org\/10.1093\/ckj\/sfae010 (2024).","journal-title":"Clin. Kidney J."},{"key":"26378_CR58","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1053\/j.ajkd.2020.05.017","volume":"76","author":"OA Potok","year":"2020","unstructured":"Potok, O. A. et al. The difference between Cystatin C- and Creatinine-Based estimated GFR and associations with frailty and adverse outcomes: A cohort analysis of the systolic blood pressure intervention trial (SPRINT). Am. J. Kidney Diseases: Official J. Natl. Kidney Foundation. 76, 765\u2013774. https:\/\/doi.org\/10.1053\/j.ajkd.2020.05.017 (2020).","journal-title":"Am. J. Kidney Diseases: Official J. Natl. Kidney Foundation"},{"key":"26378_CR59","doi-asserted-by":"publisher","first-page":"e23849","DOI":"10.1002\/jcla.23849","volume":"35","author":"IS Tzeng","year":"2021","unstructured":"Tzeng, I. S. To handle the inflation of odds ratios in a retrospective study with a profile penalized log-likelihood approach. J. Clin. Lab. Anal. 35, e23849. https:\/\/doi.org\/10.1002\/jcla.23849 (2021).","journal-title":"J. Clin. Lab. Anal."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-26378-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-26378-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-26378-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T12:55:06Z","timestamp":1764248106000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-26378-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,27]]},"references-count":59,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["26378"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-26378-2","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,27]]},"assertion":[{"value":"13 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"42370"}}